Welcome to InfiCure Bio
InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.
Based on a panel of in vivo models for these conditions including a proprietary model, the NIF mouse, for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.
Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.
News
Winners – New entrepreneur of the year!
Yesterday, InfiCure Bio was announced as the winners in the category "New entrepreneur of the year" at Umeågalan. We are very proud and happy that our work to help cure fibrosis is awarded. This award [...]
Umeågalan – nominated again!
InfiCure Bio is nominated for Umeågalan again! This time we are one of three companies nominated in the category "New Entrepreneur of the Year", which feels very honorable. We are looking forward to a fun [...]
InfiCure Bio is part of the Catalyst program
InfiCure Bio has been accepted to Business Swedens Catalyst program, which is a program aimed at helping companies scale globally. The focus for InfiCure Bio is the Korean market and Business Sweden will help InfiCure to [...]
InfiCure Bio presenting at LSX Nordic
The CEO of InfiCure Bio presented the company at LSX Nordics in Stockholm on August 28th. To watch the presentation click here.